Folger Nolan Fleming Douglas Capital Management Inc. Buys 432 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Folger Nolan Fleming Douglas Capital Management Inc. grew its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 25,223 shares of the healthcare conglomerate’s stock after acquiring an additional 432 shares during the period. UnitedHealth Group comprises approximately 1.3% of Folger Nolan Fleming Douglas Capital Management Inc.’s investment portfolio, making the stock its 19th biggest holding. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in UnitedHealth Group were worth $12,759,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently bought and sold shares of UNH. M&T Bank Corp increased its holdings in shares of UnitedHealth Group by 13.4% in the 3rd quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock valued at $128,975,000 after acquiring an additional 26,074 shares during the period. Sugarloaf Wealth Management LLC raised its holdings in UnitedHealth Group by 17.6% in the fourth quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock worth $4,025,000 after purchasing an additional 1,193 shares in the last quarter. Benjamin Edwards Inc. boosted its holdings in shares of UnitedHealth Group by 1,275.3% in the 3rd quarter. Benjamin Edwards Inc. now owns 44,547 shares of the healthcare conglomerate’s stock valued at $26,060,000 after buying an additional 41,308 shares in the last quarter. Parsifal Capital Management LP bought a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $21,165,000. Finally, Signal Advisors Wealth LLC boosted its stake in UnitedHealth Group by 13.0% in the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock valued at $4,611,000 after acquiring an additional 1,051 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.1 %

Shares of UNH opened at $510.03 on Friday. The firm’s fifty day moving average is $551.50 and its two-hundred day moving average is $562.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $469.37 billion, a PE ratio of 33.23, a price-to-earnings-growth ratio of 1.42 and a beta of 0.62. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period last year, the company posted $5.83 EPS. The business’s revenue was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Investors of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.65%. The ex-dividend date of this dividend was Monday, December 9th. UnitedHealth Group’s dividend payout ratio is currently 54.72%.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on UNH. Cantor Fitzgerald restated an “overweight” rating and set a $700.00 target price on shares of UnitedHealth Group in a research note on Friday. Oppenheimer upped their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Barclays lowered their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a research report on Friday. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of $627.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.